Cargando…

Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey

PURPOSE: To evaluate palliative care for patients with gynecologic cancer in Japan. MATERIALS AND METHOD: A questionnaire asking facility characteristics, systems to coordinate palliative care, current status of end-of-life care, provision of symptom relief, palliative radiation therapy and chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Futagami, Masayuki, Yokoyama, Yoshihito, Sato, Tetsumi, Hirota, Kazuyoshi, Shimada, Muneaki, Miyagi, Etsuko, Suzuki, Nao, Fujimura, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454609/
https://www.ncbi.nlm.nih.gov/pubmed/27892676
http://dx.doi.org/10.22034/APJCP.2016.17.10.4637
_version_ 1783240858790789120
author Futagami, Masayuki
Yokoyama, Yoshihito
Sato, Tetsumi
Hirota, Kazuyoshi
Shimada, Muneaki
Miyagi, Etsuko
Suzuki, Nao
Fujimura, Masaki
author_facet Futagami, Masayuki
Yokoyama, Yoshihito
Sato, Tetsumi
Hirota, Kazuyoshi
Shimada, Muneaki
Miyagi, Etsuko
Suzuki, Nao
Fujimura, Masaki
author_sort Futagami, Masayuki
collection PubMed
description PURPOSE: To evaluate palliative care for patients with gynecologic cancer in Japan. MATERIALS AND METHOD: A questionnaire asking facility characteristics, systems to coordinate palliative care, current status of end-of-life care, provision of symptom relief, palliative radiation therapy and chemotherapy, and cases of death from gynecological cancer, was mailed to facilities treating gynecologic cancer. RESULTS: A total of 115 facilities (29.3% of the total) responded to the questionnaire. Of these, 33.0 (29.0%) had a palliative care ward. End-of-life care was managed by obstetricians and gynecologists in 72.0% of the facilities. The site where end-of-life care was provided was most often a ward in the department where the respondent worked. The waiting period for transfer to a hospice was 2 weeks or more in 52% of facilities. Before the start of primary treatment, pain control was managed by obstetrians and gynecologists in 98.0% of facilities. Palliative radiation therapy or chemotherapy was administered at 93.9% and 92.0% of facilities, respectively. Of the 115 facilities, 34.0 (29.6%) reported cases of death from gynecological cancer. There were 1,134 cases of death. The median time between the last cycle of chemotherapy and death was 85 days for all gynecological cancers. The proportion of patients receiving chemotherapy in the last 30 and 14 days of life were 17.4% and 7.1%, respectively. CONCLUSIONS: This large-scale survey showed characteristics of palliative care given to patients with gynecologic cancer in Japan. Assessment of death cases showed that the median time between the last cycle of chemotherapy and death was relatively short.
format Online
Article
Text
id pubmed-5454609
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-54546092017-08-28 Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey Futagami, Masayuki Yokoyama, Yoshihito Sato, Tetsumi Hirota, Kazuyoshi Shimada, Muneaki Miyagi, Etsuko Suzuki, Nao Fujimura, Masaki Asian Pac J Cancer Prev Research Article PURPOSE: To evaluate palliative care for patients with gynecologic cancer in Japan. MATERIALS AND METHOD: A questionnaire asking facility characteristics, systems to coordinate palliative care, current status of end-of-life care, provision of symptom relief, palliative radiation therapy and chemotherapy, and cases of death from gynecological cancer, was mailed to facilities treating gynecologic cancer. RESULTS: A total of 115 facilities (29.3% of the total) responded to the questionnaire. Of these, 33.0 (29.0%) had a palliative care ward. End-of-life care was managed by obstetricians and gynecologists in 72.0% of the facilities. The site where end-of-life care was provided was most often a ward in the department where the respondent worked. The waiting period for transfer to a hospice was 2 weeks or more in 52% of facilities. Before the start of primary treatment, pain control was managed by obstetrians and gynecologists in 98.0% of facilities. Palliative radiation therapy or chemotherapy was administered at 93.9% and 92.0% of facilities, respectively. Of the 115 facilities, 34.0 (29.6%) reported cases of death from gynecological cancer. There were 1,134 cases of death. The median time between the last cycle of chemotherapy and death was 85 days for all gynecological cancers. The proportion of patients receiving chemotherapy in the last 30 and 14 days of life were 17.4% and 7.1%, respectively. CONCLUSIONS: This large-scale survey showed characteristics of palliative care given to patients with gynecologic cancer in Japan. Assessment of death cases showed that the median time between the last cycle of chemotherapy and death was relatively short. West Asia Organization for Cancer Prevention 2016 /pmc/articles/PMC5454609/ /pubmed/27892676 http://dx.doi.org/10.22034/APJCP.2016.17.10.4637 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Futagami, Masayuki
Yokoyama, Yoshihito
Sato, Tetsumi
Hirota, Kazuyoshi
Shimada, Muneaki
Miyagi, Etsuko
Suzuki, Nao
Fujimura, Masaki
Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey
title Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey
title_full Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey
title_fullStr Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey
title_full_unstemmed Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey
title_short Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey
title_sort palliative care for patients with gynecologic cancer in japan: a japan society of gynecologic palliative medicine (jsgpm) survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454609/
https://www.ncbi.nlm.nih.gov/pubmed/27892676
http://dx.doi.org/10.22034/APJCP.2016.17.10.4637
work_keys_str_mv AT futagamimasayuki palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey
AT yokoyamayoshihito palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey
AT satotetsumi palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey
AT hirotakazuyoshi palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey
AT shimadamuneaki palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey
AT miyagietsuko palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey
AT suzukinao palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey
AT fujimuramasaki palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey